Cite
MLA Citation
Oliver Sartor et al.. “Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases.” Prostate, vol. 79, no. 14, 2019, pp. 1683–1691. http://access.bl.uk/ark:/81055/vdc_100091268379.0x00003b